What the Campaign's Legal Challenge Means for Future Payment Reform

The cardiology community in the United States has spent years watching physician payment schedules erode, and a legal fight launched by the American College of Cardiology now threatens to redraw the rules of how Medicare values specialist work. For clinicians across the Tasman, the case carries echoes of debates already playing out under Australia's own Medicare Benefits Schedule, where rebate levels for complex cardiac procedures have long been a flashpoint between specialists, government, and patient advocates.

Paying fairly for cognitive and procedural work sits at the centre of every modern payment reform discussion. When a system undervalues a consultation or a sophisticated imaging study, the downstream effects ripple through waiting lists, training pipelines, and the financial viability of small practices. Cardiologists in Sydney and Perth know this reality as intimately as their counterparts in Boston or Houston, because fee schedules everywhere tend to lag behind the actual cost of delivering modern care.

The legal challenge aims to force a reckoning with how those schedules are constructed and who gets the final say over their shape. Whether the courts side with the campaign or uphold the existing methodology will set precedents that stretch well beyond cardiovascular medicine, touching every specialty that depends on accurate valuation of physician time and expertise.

Origins of the Legal Challenge

The campaign's decision to pursue litigation rather than rely on administrative advocacy alone reflects frustration with years of incremental cuts and opaque formula adjustments. Medicare's physician fee schedule has long been criticised for undervaluing cognitive services relative to procedural ones, and cardiology sits at the intersection of both. The legal team argues that the methodology used to calculate conversion factors fails to account for inflation, practice cost changes, and the increasing complexity of patient care.

Frustration has built across multiple review cycles. Specialists point to a pattern in which budget neutrality requirements effectively punish one group of providers whenever another receives an upgrade, leaving the total pot of funding largely unchanged. For a field that combines office-based evaluation, hospital rounds, invasive procedures, and remote monitoring, that arithmetic rarely adds up.

The campaign maintains that the issue extends beyond cardiology to the integrity of the entire payment system. Patients, the argument goes, ultimately bear the cost when practices close, scopes of service narrow, or trainees choose better-reimbursed specialties. The legal filing seeks not just a financial remedy but a structural review of how physician work is measured in the first place.

What the Court Filing Argues

The complaint outlines several core grievances that frame how payment reform might evolve if the challenge succeeds.

• The conversion factor has not kept pace with inflation or practice cost growth, eroding real reimbursement for cognitive cardiology services over more than a decade.
• Budget neutrality rules applied within the fee schedule punish specialties that innovate, because savings in one area are immediately redistributed elsewhere rather than reinvested in patient access.
• The Secretary of Health has wielded broad authority to adjust values without sufficient legislative or judicial oversight, creating an accountability gap.
• Patient access, particularly in rural and underserved communities, depends on stable practice economics that the current methodology undermines.

These arguments, taken together, suggest that any meaningful reform will need to address not just dollar values but the governance structures that produce them.

Payment Model Stakes for Specialists

Specialty societies across the US have watched the cardiology challenge with unusual attention, because the precedent could reshape how every procedural field negotiates its place in the fee schedule. Anaesthesia, radiology, orthopaedics, and gastroenterology all operate under the same conversion factor and budget neutrality constraints. A successful legal argument that these mechanisms are unlawful could open the door to parallel claims or administrative reforms across the board.

Practices have already begun adapting to the uncertainty. Some cardiology groups in regional New South Wales and Queensland have consolidated to absorb overhead, while others have shifted toward hospital employment to insulate themselves from fee schedule volatility. These structural responses mirror what has happened in parts of regional Australia, where cardiology outreach services have gradually moved from private consulting rooms into larger hospital networks as MBS rebates failed to cover the true cost of running a sustainable practice.

The deeper stakes involve workforce planning. Trainees considering cardiology weigh expected lifetime earnings against the length and rigour of training. When reimbursement compresses, fewer medical graduates choose the specialty, and access erodes long before any single fee schedule cut makes headlines. Reform that fails to address this pipeline risk risks solving a budget problem while creating a workforce one.

What Australian Clinicians Can Take Away

Across the ditch, cardiologists and health policy watchers can draw several practical lessons from the US legal fight. At the end of the day, both systems wrestle with the same gap between technical reform and political reality, even when the policy language around them sounds quite different.

• Watch how the courts treat the technical argument that fee schedule methodology violates statutory requirements, as similar reasoning has been raised in Australian administrative law challenges against MBS decisions.
• Compare how the Medicare physician fee schedule handles cognitive versus procedural valuation, since the MBS has faced identical criticism from the Royal Australian College of Physicians.
• Note the role of patient storytelling in shifting public opinion, a tactic Australian advocacy groups have used effectively in campaigns around PBS listings and bulk billing incentives.
• Track any reform package that emerges from a settlement, as funding reallocations often preview the direction of future MBS reviews.
• Consider how rural loading incentives in Australia might be replicated or expanded in the US to preserve access where payment reform threatens viability.

These lessons highlight how payment systems in different countries face surprisingly similar structural tensions, even when the political language around them diverges.

Comparing Reform Pathways Across Borders

Reform Element	United States (Medicare)	Australia (MBS)
Primary Valuation Body	CMS / RUC process	Department of Health and Aged Care / MSAC
Cognitive vs Procedural Balance	Frequently criticised as skewed	Subject to ongoing Royal College advocacy
Patient Cost Exposure	Limited under Medicare, higher with supplemental plans	Bulk billing incentives reduce gap fees
Legal Challenge Route	Federal court litigation, regulatory comment	Administrative Appeals Tribunal, judicial review
Workforce Adjustment Tool	Geographic payment adjustments, loan repayment	Rural loading, district of workforce shortage classification

Both systems struggle with the same fundamental tension: how to value physician work accurately when the inputs change faster than the schedule can be updated. The Australian experience with the MBS review process shows that even sustained technical reform leaves stakeholder groups dissatisfied, particularly when reform cycles stretch across multiple government terms.

Looking Ahead to the Next Phase of Reform

Whatever the court decides, the legal action has already shifted the conversation. Payment reform in the US has tended to unfold behind closed doors within the Centers for Medicare and Medicaid Services, with specialty societies fighting over relative values through committee work and comment letters. Bringing the methodology into a public courtroom raises the visibility of decisions that have long escaped broader scrutiny.

For Australian observers, the most interesting development will be whether US reform produces a template worth borrowing or a cautionary tale. The history of fee schedule reform in Australia, including repeated reviews of cardiac procedure rebates and the slow expansion of items for complex implantable device management, suggests that technical fixes rarely satisfy anyone for long. A successful legal challenge could break that cycle, or it could simply relocate the political fight from advisory committees to courtrooms without changing the underlying economics.

Patients, meanwhile, have the most to gain or lose. Access to specialist cardiology depends on a fragile chain of training, reimbursement, and practice sustainability. Breaking any link produces waiting lists, longer travel times, and delayed diagnoses. The campaign's bet is that courts will recognise the human stakes behind the technical arguments. Whether that bet pays off will shape cardiology practice on both sides of the Pacific for the next generation.

Specialists, patients, and practice managers who want to understand the full scope of what is at stake can review the campaign's issue page and consider adding their voice to the broader conversation about how physician work should be valued in a modern healthcare system.